Browse result page of THPdb

The total number entries retrieved from this search are 94

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1001	ThPPIDTh1001	NameLepirudin	Peptide SequenceLVYTDCTESGQNLCLCEGSN Full view	Length65	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandRefludan	CompanyBerlex Labs	Physical AppearanceSterile, white, freeze-dried powder	Route of AdministartionIntravenous infusion	CategoryAntithrombins and Fibrinolytic Agents	TargetProthrombin
ID1032	ThPPIDTh1006	NameBivalirudin	Peptide SequenceFPRPGGGGNGDFEEIPEEYL Full view	Length20	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAngiomax	CompanyMedicines Co or MDCO	Physical AppearanceWhite lyophilized cake in single-use vials	Route of AdministartionIntravenous infusion	CategoryAntithrombins	TargetProthrombin
ID1033	ThPPIDTh1006	NameBivalirudin	Peptide SequenceFPRPGGGGNGDFEEIPEEYL Full view	Length20	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAngiox	CompanyThe Medicines Company UK Ltd	Physical AppearancePowder for concentrate for solution	Route of AdministartionInjection	CategoryAntithrombins	TargetProthrombin
ID1148	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAdvate	CompanyN.A.	Physical AppearancePowder form	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1149	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandAlphanate	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1150	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandBioclate	CompanyBaxter Healthcare Corporation, Hyland Division and Genetics Institute, Inc.	Physical AppearanceSterile, nonpyrogenic, off-white to faint yellow, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1151	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHelixate FS	CompanyN.A.	Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1152	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHemofil M	CompanyN.A.	Physical AppearanceDry concentrate	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1153	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandHyate:C	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1154	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandKoate-HP	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1155	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandKogenate FS	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1156	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandMonarc-M	CompanyN.A.	Physical AppearancePowder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1157	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandMonoclate-P	CompanyN.A.	Physical AppearanceLyophilized powder for solution	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1158	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandReFacto	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1159	ThPPIDTh1022	NameAntihemophilic Factor	Peptide SequenceATRRYYLGAVELSWDYMQSD Full view	Length255	Functional ClassificationIa	DiseaseHematological,Metabolic	BrandXyntha	CompanyN.A.	Physical AppearanceSterile, nonpyrogenic, preservative-free, freeze-dried powder	Route of AdministartionIntravenous Injection	CategoryCoagulants and Thrombotic agents	TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1193	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandCivacir	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1194	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandFlebogamma	CompanyInstituto Grifols SA	Physical AppearanceSterile, clear or slightly opalescent and colorless to pale yellow, liquid	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1195	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandGamunex	CompanyTalecris Biotherapeutics	Physical AppearanceSterile solution	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1205	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandHumulin R	CompanyEli Lilly and Company	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous injection in the abdominal wall, the thigh, the gluteal region or in the upper arm and Intravenousadministration of Humulin R (insulin (human recombinant)) U-100 is possible under medical supervision.	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1206	ThPPIDTh1027	NameInsulin Regular	Peptide SequenceA-chain:GIVEQCCTSIC< Full view	Length51	Functional ClassificationIa	DiseaseGenetic/Hormonal	BrandNovolin R	CompanyNovo Nordisk	Physical AppearanceSterile, clear, aqueous, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryAntidiabetic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Retinoblastoma-associated protein,Cathepsin D,Insulin-degrading enzyme,Neuroendocrine convertase 2,Carboxypeptidase E,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-r
ID1275	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog	CompanyEli Lilly	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1276	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog KwikPen	CompanyEli Lilly	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1277	ThPPIDTh1040	NameInsulin Lispro	Peptide SequenceA chain:GIVEQCCTSICS Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandHumalog Pen	CompanyEli Lilly	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1283	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus	CompanySanofi-Aventis	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1284	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus OptiSet	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1285	ThPPIDTh1041	NameInsulin Glargine	Peptide SequenceA-chain:GIVEQCCTSICS Full view	Length53	Functional ClassificationIa	DiseaseHormonal/Metabolic/genetic	BrandLantus SoloStar	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents, Antidiabetic agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor
ID1324	ThPPIDTh1045	NameImiglucerase	Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view	Length255	Functional ClassificationIa	DiseaseMetabolic	BrandCerezyme	CompanyGenzyme	Physical AppearanceSterile, non-pyrogenic, white to off-white lyophilized product	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetGlucocerebroside
ID1358	ThPPIDTh1050	NamePegademase bovine	Peptide SequenceMAQTPAFNKPKVELHVHLDG Full view	Length255	Functional ClassificationIa	DiseaseMetabolic	BrandAdagen	CompanyEnzon Inc.	Physical AppearanceIsotonic, pyrogen free, sterile solution, pH 7.2-7.4	Route of AdministartionIntramusular Injection	CategoryEnzyme Replacement Agents	TargetAdenosine,Growth factor receptor-bound protein 2
ID1361	ThPPIDTh1051	NameHuman Serum Albumin	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length609	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlbuminar	CompanyCSL Behring	Physical AppearanceSterile aqueous solution of albumin obtained from large pools of adult human venous plasma by low temperature controlled fractionation according to the Cohn process.	Route of AdministartionAlbumin (Human) 25%, Albuminar-25 (albumin human) , is to be administered by the Intravenous route.	CategorySerum substitutes	TargetN.A.
ID1362	ThPPIDTh1051	NameHuman Serum Albumin	Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view	Length609	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlbutein	CompanyGRIFOLS	Physical AppearanceSterile, aqueous solution for single dose intravenous administration containing 20% human albumin (weight/volume).	Route of AdministartionAlbutein 20% is to be administered by the Intravenous route.	CategorySerum substitutes	TargetN.A.
ID1382	ThPPIDTh1060	NameInsulin, porcine	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	Brandvetsulin	CompanyIntervet Inc (Merck Animal Health)	Physical AppearanceSterile injectable suspension in multidose vials containing 10 mL of 40 IU/mL porcine insulin zinc suspension	Route of AdministartionSubcutaneous Injection	CategoryHypoglycemic Agents	TargetInterferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Hyaluronan, Transforming growth factor beta-1
ID1422	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPancrecarb	CompanyDigestive care US, Inc.	Physical AppearanceDelayed-Release Capsules, Buffered and Enteric-Coated Microspheres.	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1423	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandViokace	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble in alcohol and converted to tablet form	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1424	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRESA	CompanyAptalis Pharma US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether and converted to Delayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1425	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandPERTZYE	CompanyDigestive care US, Inc.	Physical AppearanceBeige-white amorphous powder, miscible in water and practically insoluble or insoluble in alcohol and ether PERTZYE delayed-release capsule	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1426	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandULTRASE	CompanyAxcan Pharma	Physical AppearanceCapsules Enteric-Coated Microspheres	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1427	ThPPIDTh1071	NamePancrelipase	Peptide SequencePancreatic alpha amy Full view	Length1206	Functional ClassificationIa	DiseaseMetabolic/genetic/	BrandZENPEP	CompanyAptalis Pharma US, Inc.	Physical AppearanceDelayed-Release Capsules	Route of AdministartionOral route	CategoryGastrointestinal Agents and Enzyme Replacement Agents	TargetSynaptosomal-associated protein 25,Rho-related GTP-binding protein RhoB, Dietary fat,Dietary protein,Dietary starch
ID1434	ThPPIDTh1074	NameAlglucerase	Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view	Length497	Functional ClassificationIa	DiseaseMetabolic	BrandCeredase	CompanyGenzyme Corporation	Physical AppearanceClear sterile non-pyrogenic solution of alglucerase in a citrate buffered solution	Route of AdministartionIntravenous injection	CategoryEnzyme Replacement Agents	TargetPlasminogen,Proteinase-activated receptor 1
ID1437	ThPPIDTh1076	NameLaronidase	Peptide SequenceAPHLVQVDAARALWPLRRFW Full view	Length626	Functional ClassificationIa	DiseaseMetabolic	BrandALDURAZYME	CompanyGenzyme Corporation	Physical AppearanceSterile, nonpyrogenic, colorless to pale yellow, clear to slightly opalescent solution that must be diluted prior to administration in 0.9% Sodium Chloride Injection	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetN.A.
ID1453	ThPPIDTh1083	NameCoagulation Factor Ix	Peptide SequenceYNSGKLEEFVQGNLERECME Full view	Length415	Functional ClassificationIa	DiseaseHematological/Metabolic/genetic	BrandAlprolix	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, non-pyrogenic, preservative-free, white to off-white, lyophilized powder to cake for reconstitution with the provided diluent	Route of AdministartionIntravenous infusion	CategoryCoagulants and Thrombotic Agents	TargetN.A.
ID1455	ThPPIDTh1085	NameAgalsidase Beta	Peptide SequenceLDNGLARTPTMGWLHWERFM Full view	Length398	Functional ClassificationIa	DiseaseMetabolic	BrandFabrazyme	CompanyGenzyme Corp	Physical AppearanceSterile, nonpyrogenic, white to off-white, lyophilized cake or powder for reconstitution with Sterile Water for Injection	Route of AdministartionN.A.	CategoryEnzyme Replacement Agents	TargetN.A.
ID1473	ThPPIDTh1093	NameEculizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIa	DiseaseHaemetological	BrandSoliris	CompanyAlexion, Inc	Physical AppearanceSterile, clear, colorless, preservative-free 10 mg/mL solution for intravenous infusion	Route of AdministartionN.A.	CategoryN.A.	TargetComplement C5
ID1476	ThPPIDTh1096	NameIdursulfase	Peptide SequenceSETQANSTTDALNVLLIIVD Full view	Length525	Functional ClassificationIa	DiseaseMetabolic	BrandElaprase	CompanySHIRE	Physical AppearanceSterile, nonpyrogenic clear to slightly opalescent, colorless solution that must be diluted prior to administration in 0.9% Sodium Chloride Injection, USP	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetDermatan sulfate,Heparan sulfate,Perilipin-3
ID1482	ThPPIDTh1100	NamePramlintide	Peptide SequenceKCNTATCATQRLANFLVHSS Full view	Length37	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandSymlin	CompanyAmylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca)	Physical AppearanceClear, isotonic, sterile solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetCalcitonin receptor,Receptor activity-modifying protein 1,Receptor activity-modifying protein 2,Receptor activity-modifying protein 3
ID1494	ThPPIDTh1101	NameGalsulfase	Peptide SequenceSGAGASRPPHLVFLLADDLG Full view	Length497	Functional ClassificationIa	DiseaseMetabolic	BrandNaglazyme	CompanyBioMarin	Physical AppearanceSterile, nonpyrogenic, colorless to pale yellow, clear to slightly opalescent solution that must be diluted with 0.9% Sodium Chloride Injection, USP, prior to administration	Route of AdministartionIntravenous infusion	CategoryEnzyme Replacement Agents	TargetDermatan sulfate,Perilipin-3
ID1502	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog	CompanyNovo Nordisk	Physical AppearanceSterile, aqueous, clear, and colorless solution	Route of AdministartionSubcutaneous injection, Intravenous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1503	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 50/50	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1504	ThPPIDTh1105	NameInsulin Aspart	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandNovoLog Mix 70/30	CompanyNovo Nordisk	Physical AppearanceUniform, white, sterile suspension that contains insulin aspart 100 Units/mL.	Route of AdministartionSubcutaneous injection	CategoryHypoglycemic Agents and Antidiabetic Agents	TargetInsulin receptor
ID1511	ThPPIDTh1106	NameInsulin Detemir	Peptide SequenceA chain: GIVEQCCTSIC Full view	Length51	Functional ClassificationIa	DiseaseHormonal/Metabolic	BrandLEVEMIR	CompanyNovo Nordisk	Physical AppearanceClear, colorless, aqueous, neutral sterile solution	Route of AdministartionSubcutaneous injection	CategoryAntidiabetic Agents	TargetInsulin receptor
ID1602	ThPPIDTh1128	NameVelaglucerase Alfa	Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view	Length497	Functional ClassificationIa	DiseaseHormonal	BrandVPRIV	CompanyShire	Physical AppearanceSterile, preservative free, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryEnzymes	TargetGlucosylceramidase